The practical use of phosphocreatine in acute myocardial infarction on the background of intra-aortic balloon pump therapyAuthor(s): L.V. Shekhovtsova, Belgorod National Research University, Belgorod, Russia
E.A. Artemova, Ltd. Heart clinic, Stary Oskol, Russia
O.A. Osipova, Dr., Prof., Belgorod National Research University, Belgorod, Russia, email@example.com
A.I. Golovin, Belgorod National Research University, Belgorod, Russia
Issue: Volume 42, № 2
Annotation: Sometimes in practice, the cardiologist has to deal with situations in which insufficient compliance with treatment approaches described in clinical guidelines and standards of care. In the treatment of a patient with acute myocardial infarction, the primary task is to maintain a viable myocardium, restore the pumping function of the heart, which affects the near and long-term prognosis of life. The use of drugs, in addition to standard therapy, sometimes helps to cope with the critical condition of the patient and thus save his life. And the use of assistive devices can help bring the patient out of the critical state, thereby saving his life. An example of the positive effect of the use of phosphocreatine can serve as our clinical case. The case of management of a patient with acute myocardial infarction complicated by cardiogenic shock of II degree and alveolar pulmonary edema is presented. Given the unstable hemodynamics, non-canceling pulmonary edema, an intra-aortic balloon counterpulsator installed in the descending aorta was used. Also in the scheme of treatment was used phosphocreatine by the appropriate scheme, which has had a pronounced protective action on the myocardium and contributed to the relief of arrhythmias when added to standard therapy in the first days of the disease.
Keywords: рhosphocreatine, acute myocardial infarction, intra-aortic balloon counter-pulsator, coronarography.
Full text (PDF): Download
Downloads count: 102